Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Lacosamide products are in shortage in Canada (6 of 34 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 10, 2026.
An anticonvulsant used to treat certain types of seizures in epilepsy.
Products affected
6 / 34
In shortage since
Sep 22, 2022
Est. full return
Aug 10, 2026
Reports on file
81
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
TEVA-LACOSAMIDE
100MG · TABLET · TEVA CANADA LIMITED
DIN 02472910 · since Jun 3, 2026, est. end Aug 10, 2026 · Disruption of the manufacture of the drug.
Active shortage
LACOSAMIDE INJECTION, USP
10MG · SOLUTION · HIKMA CANADA LIMITED
DIN 02541343 · since ?, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortage
ACH-LACOSAMIDE
200MG · TABLET · ACCORD HEALTHCARE INC
DIN 02489317 · since Sep 22, 2022, no end estimate · Disruption of the manufacture of the drug.
Active shortage
ACH-LACOSAMIDE
150MG · TABLET · ACCORD HEALTHCARE INC
DIN 02489309 · since Sep 22, 2022, no end estimate · Disruption of the manufacture of the drug.
Active shortage
ACH-LACOSAMIDE
100MG · TABLET · ACCORD HEALTHCARE INC
DIN 02489295 · since Sep 22, 2022, no end estimate · Disruption of the manufacture of the drug.
Active shortage
ACH-LACOSAMIDE
50MG · TABLET · ACCORD HEALTHCARE INC
DIN 02489287 · since Sep 22, 2022, no end estimate · Disruption of the manufacture of the drug.
Resolved
TEVA-LACOSAMIDE
150MG · TABLET · TEVA CANADA LIMITED
DIN 02472929 · ended Jun 3, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-LACOSAMIDE
100MG · TABLET · TEVA CANADA LIMITED
DIN 02472910 · ended Apr 22, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-LACOSAMIDE
50MG · TABLET · TEVA CANADA LIMITED
DIN 02472902 · ended Apr 15, 2026 · Disruption of the manufacture of the drug.
Resolved
VIMPAT
150MG · TABLET · UCB CANADA INC
DIN 02357631 · ended Mar 20, 2026 · Delay in shipping of the drug.
Resolved
TEVA-LACOSAMIDE
200MG · TABLET · TEVA CANADA LIMITED
DIN 02472937 · ended Mar 10, 2026 · Disruption of the manufacture of the drug.
Resolved
LACOSAMIDE
50MG · TABLET · SANIS HEALTH INC
DIN 02512874 · ended Jan 24, 2025 · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Lacosamide is currently affected by 6 active shortage reports filed with Health Canada by TEVA CANADA LIMITED, HIKMA CANADA LIMITED, ACCORD HEALTHCARE INC.
The reported causes are: disruption of the manufacture of the drug; requirements related to complying with good manufacturing practices. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Lacosamide is classified under “ANTIEPILEPTICS” (ATC N03AX).
Recent changes
No changes recorded yet.
Common questions
What is Lacosamide used for?
An anticonvulsant used to treat certain types of seizures in epilepsy.
When will Lacosamide be back in stock in Canada?
The latest manufacturer estimate is Aug 10, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Lacosamide in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Possible alternatives in the same class (antiepileptics)
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.